These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17612029)

  • 1. [Abstracts of the ASN, EASD and ISH 2006 Congresses on Diabetic Nephropathy].
    Nephrol Ther; 2007 Apr; 3 Spec.No. 1():1-11. PubMed ID: 17612029
    [No Abstract]   [Full Text] [Related]  

  • 2. University Diabetes Outreach Project (UNDOP) Diabetic Nephropathy Symposium. Mona, Jamaica, January 23-24, 1993. Abstracts.
    West Indian Med J; 1993 Jul; 42 Suppl 2():1-8. PubMed ID: 7904391
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging role of PPAR ligands in the management of diabetic nephropathy.
    Balakumar P; Arora MK; Singh M
    Pharmacol Res; 2009 Sep; 60(3):170-3. PubMed ID: 19646656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of diabetic nephropathy--old buddies and newcomers part 2.
    Nawroth PP; Isermann B
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):667-72. PubMed ID: 20658437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update.
    Arora MK; Singh UK
    Vascul Pharmacol; 2013 Apr; 58(4):259-71. PubMed ID: 23313806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.
    Ioannou K
    Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling and podocyte dysfunction in diabetic nephropathy.
    Bose M; Almas S; Prabhakar S
    J Investig Med; 2017 Dec; 65(8):1093-1101. PubMed ID: 28935636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report for the EASD-Bayer Travel Fellowship for Young Scientist 1997. European Association of the Study of Diabetes.
    Jones SM
    Diabetologia; 1998 Mar; 41(3):20. PubMed ID: 9541183
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of anti-inflammation and immune regulation in the treatment of diabetic nephropathy].
    Zhang X; Lu FE
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):649-54. PubMed ID: 20815285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery for diabetic nephropathy: trying the leap from mouse to man.
    Breyer MD
    Semin Nephrol; 2012 Sep; 32(5):445-51. PubMed ID: 23062985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.
    Haneda M; Utsunomiya K; Koya D; Babazono T; Moriya T; Makino H; Kimura K; Suzuki Y; Wada T; Ogawa S; Inaba M; Kanno Y; Shigematsu T; Masakane I; Tsuchiya K; Honda K; Ichikawa K; Shide K
    Clin Exp Nephrol; 2015 Feb; 19(1):1-5. PubMed ID: 25527479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the genetics of diabetic nephropathy through the study of mice.
    Breyer MD; Qi Z; Tchekneva EE; Harris RC
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):82-6. PubMed ID: 18090675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of diabetic nephropathy: lessons from mice.
    Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Zhao HJ; Harris RC
    Semin Nephrol; 2007 Mar; 27(2):237-47. PubMed ID: 17418691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic nephropathy, early diabetic nephropathy].
    Araki S; Kikkawa R
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):221-4. PubMed ID: 9277901
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions.
    Balakumar P; Arora MK; Ganti SS; Reddy J; Singh M
    Pharmacol Res; 2009 Jul; 60(1):24-32. PubMed ID: 19427582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of diabetic nephropathy: a long road of discovery.
    McKnight AJ; Duffy S; Maxwell AP
    Curr Diab Rep; 2015 Jul; 15(7):41. PubMed ID: 25971618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy.
    Wang J; Duan L; Guo T; Gao Y; Tian L; Liu J; Wang S; Yang J
    J Diabetes Complications; 2016 Apr; 30(3):406-14. PubMed ID: 26775556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic nephropathy: leveraging mouse genetics.
    Breyer MD; Qi Z; Tchekneva E
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):227-32. PubMed ID: 16609287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.